Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

DR REDDYS

  • FDA Approval
  • Feb. 21, 2025, 09:59 UTC
  • 33

FDA approve PALIPERIDONE

Comment Full text

HIKMA

  • FDA Approval
  • Feb. 21, 2025, 09:59 UTC
  • 42

FDA approve PROCHLORPERAZINE EDISYLATE

Comment Full text

NEXUS

  • FDA Approval
  • Feb. 21, 2025, 09:59 UTC
  • 33

FDA approve PROCHLORPERAZINE EDISYLATE

Comment Full text

EPIC PHARMA

  • FDA Approval
  • Feb. 21, 2025, 09:59 UTC
  • 52

FDA approve TRANDOLAPRIL

Comment Full text

HIKMA

  • FDA Approval
  • Feb. 21, 2025, 09:59 UTC
  • 49

FDA approve PROCHLORPERAZINE EDISYLATE

Comment Full text

ALEMBIC

  • FDA Approval
  • Feb. 21, 2025, 09:59 UTC
  • 45

FDA approve TADALAFIL

Comment Full text

WATSON LABS

  • FDA Approval
  • Feb. 21, 2025, 09:59 UTC
  • 32

FDA approve CLORAZEPATE DIPOTASSIUM

Comment Full text

BARR

  • FDA Approval
  • Feb. 21, 2025, 09:59 UTC
  • 35

FDA approve GALANTAMINE HYDROBROMIDE

Comment Full text

WATSON LABS

  • FDA Approval
  • Feb. 21, 2025, 09:59 UTC
  • 42

FDA approve CLORAZEPATE DIPOTASSIUM

Comment Full text

WATSON LABS

  • FDA Approval
  • Feb. 21, 2025, 09:59 UTC
  • 40

FDA approve CLORAZEPATE DIPOTASSIUM

Comment Full text
  • Previous
  • 95
  • 96
  • 97
  • 98
  • 99
  • Next

Search

News categories

  • Technical Exchange News(9542)
  • Event(407)
  • SEC News(156360)
  • FDA Approval(8925)
  • Company Report(721)
  • Business News(106110)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin